MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway

MIEF2 (mitochondrial elongation factor 2) is one of the key regulators of mitochondrial fission. Bioinformatics analysis indicated that high expression of MIEF2 predicted a poor prognosis in ovarian cancer patients. However, the relationship between MIEF2 and aberrant lipid metabolism in OC remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuhua, Cheng, Lu, Shi, Yuan, Li, Jia, Yun, Qinghui, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791105/
https://www.ncbi.nlm.nih.gov/pubmed/33414447
http://dx.doi.org/10.1038/s41419-020-03336-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791105/
https://www.ncbi.nlm.nih.gov/pubmed/33414447
http://dx.doi.org/10.1038/s41419-020-03336-6

Ejemplares similares